ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France.
about
EAACI position paper on occupational rhinitis.Survey on the impact of comorbid allergic rhinitis in patients with asthma.Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases.Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica study.Exogenous lipid pneumonia related to long-term use of Vicks VapoRub® by an adult patient: a case reportThe hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey.Management of allergic rhinitis in general practitionersUK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational studyPatient adherence to allergic rhinitis treatment: results from patient surveys.Practical guide to skin prick tests in allergy to aeroallergens.Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States.MP29-02: a breakthrough for the treatment of allergic rhinitis.Management of allergic rhinitis: a common part of practice in primary care clinics.Validation of the classification of ARIA (allergic rhinitis and its impact on asthma).Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study.Nasal corticosteroids, first choice in moderate to severe allergic rhinitis. What prevents general practitioners from using them?Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.Characteristics of patients with respiratory allergy in France and factors influencing immunotherapy prescription: a prospective observational study (REALIS).Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: a retrospective, observational study.Classification and management of allergic rhinitis patients in general practice during pollen season.Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax-a real life study.Economic evaluation of a computed tomography directed referral strategy for chronic rhinosinusitis.[Adherence in specific immunotherapy].Introduction: allergic rhinitis.National survey on the management of rhinopathies in asthma patients by French pulmonologists in everyday practice.
P2860
Q28387816-2845992F-1E54-478E-A159-2A726F2D060AQ33265227-9A916920-7FFC-457E-A536-05F923ADDB76Q33686509-ACA0144A-DAE0-4493-9FB2-6197371CB150Q35146166-2E16E7FD-C70E-4FAB-A794-4B79F2F9E916Q36108751-B0A07B04-1B97-427E-9AED-7986248AE31BQ36294156-232912A0-3413-4990-971A-3CBDB722C3C4Q36365152-FB046C56-8D3C-4DDC-9090-6203AB62B51BQ37031239-48FE6E28-DDCC-402D-8FFC-044D6F91A81BQ37355776-38475A6B-3ACE-49C1-B29A-A339D7F7EC67Q37952280-B2F5E6B0-C26C-4588-9BFE-1CFC1029A6A2Q38062585-BEE56427-382F-490A-A14C-1D4654A55429Q38131527-F5B5E1C0-0098-4CDC-AC02-3307F0F93B02Q39383994-1108C841-91E4-44F3-BFC8-D1A23C34B558Q39652968-FDD82EFC-C12D-4EC1-B6BA-EB504D2F7C8EQ41634075-9934B8D4-9FCE-4747-992A-406DB82F4C7DQ44512143-88FFD70D-7EAA-467F-8D3D-FB87DBFCE8C6Q44800324-CE45C0B8-35FB-40F6-8B45-571C8948FBBEQ45912679-13B27FC7-0DB6-46CD-9171-D6F72CF5316AQ47898498-E97D30D4-7DE8-475C-AB64-4DD25C8D10CBQ49084611-5B7D3CEE-69CC-4796-AD53-A4D1EE72A197Q49508636-AD89170F-F35E-4C67-A1F8-2D105F287D63Q50868624-E36B0E8B-B708-4CFA-AE96-B98B0BAE7EB8Q52718381-6D63E59B-9D87-473A-A944-E05655044F15Q53167112-320151F4-CB24-40EF-8E18-85BD2A0AECA1Q53393081-C47CF26E-9E65-4130-B10F-BC4A8ADAA028
P2860
ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
ERASM, a pharmacoepidemiologic ...... al medical practice in France.
@en
ERASM, a pharmacoepidemiologic ...... al medical practice in France.
@nl
type
label
ERASM, a pharmacoepidemiologic ...... al medical practice in France.
@en
ERASM, a pharmacoepidemiologic ...... al medical practice in France.
@nl
prefLabel
ERASM, a pharmacoepidemiologic ...... al medical practice in France.
@en
ERASM, a pharmacoepidemiologic ...... al medical practice in France.
@nl
P2860
P1433
P1476
ERASM, a pharmacoepidemiologic ...... ral medical practice in France
@en
P2093
P2860
P304
P356
10.1034/J.1398-9995.2002.T01-1-13370.X
P577
2002-06-01T00:00:00Z